Central Retinal Artery Occlusion: Clinical Trials

3 trials for Central Retinal Artery Occlusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1

Follow Central Retinal Artery Occlusion: new trials by email Literature Review of Central Retinal Artery Occlusion trials Research Report on Central Retinal Artery Occlusion

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion
Tenecteplase (until trial protocol V04: Alteplase) - Central Retinal Artery Occlusion
Phase 3TerminatedUniversity Hospital Tuebingen1272022-10-102026-05-18
TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)
Intravenous injection of Tenecteplase and one dose of placebo tablet, One tablet of Acetylsalicylic Acid and one dose of IV placebo - Central Retinal Artery Occlusion
Phase 3CompletedOslo University Hospital812020-10-302025-09-29
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
Alteplase, acetylsalicylic acid, Placebo Oral Tablet - Central Retinal Artery Occlusion
Phase 3CompletedNantes University Hospital702018-06-082024-01-24

Narrower conditions

Retinal Artery Occlusion (3)

Broader conditions

Arterial Occlusive Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Eye Diseases (3)  ·  Retinal Diseases (3)  ·  Vascular Diseases (3)

Interventions

Aspirin (2)  ·  Tenecteplase (2)  ·  Tissue Plasminogen Activator (1)

Sponsors

Nantes University Hospital (1)  ·  Oslo University Hospital (1)  ·  University Hospital Tuebingen (1)

Countries

Belgium (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Lithuania (1)  ·  Norway (1)  ·  Sweden (1)

Results publications

PMID 39614619, PMID 41109232, PMID 41604638

NIH funding

2018 (1)